AbbVie Inc (NYSE:ABBV)
AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a
research-based biopharmaceutical company. The Company is engaged in the
discovery, development, manufacture and sale of a range of
pharmaceutical products. Its products are focused on treating
conditions, such as chronic autoimmune diseases in rheumatology,
gastroenterology and dermatology; oncology, including blood cancers;
virology, including hepatitis C virus (HCV) and human immunodeficiency
virus (HIV); neurological disorders, such as Parkinson's disease and
multiple sclerosis; metabolic diseases, including thyroid disease and
complications associated with cystic fibrosis, and other serious health
conditions. It offers products in various categories, including HUMIRA
(adalimumab), Oncology products, Virology Products, Additional Virology
products, Metabolics/Hormones products, Endocrinology products and other
products.
No comments:
Post a Comment